Kazuo Momma

Kazuo Momma

Auto-generated profile, based on publicly available information

Kazuo Momma

Tokyo Women’s Medical University

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in The American Journal of Cardiology
Verified
Journal Article
Closed access
KMKazuo Momma
Kazuo Momma

1 January 2006 in Pediatric Drugs
Verified
Journal Article
Closed access
PDF file
KMKazuo Momma
Kazuo Momma

23 August 1996 in American Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
HHHamao Hirota
Hamao Hirota
RMRumiko Matsuoka
Rumiko Matsuoka
MKMisa Kimura
Misa Kimura
SIShin-Ichiro Imamura
Shin-Ichiro Imamura
KJKunitaka Joh-O
Kunitaka Joh-O
KMKazuo Momma
Kazuo Momma

31 December 2005 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
KMKazuo Momma
Kazuo Momma
KTKatsuaki Toyoshima
Katsuaki Toyoshima
DTDaiji Takeuchi
Daiji Takeuchi
SIShinichiro Imamura
Shinichiro Imamura
TNToshio Nakanishi
Toshio Nakanishi

11 December 2008 in Neonatology
Verified
Journal Article
Closed access
PDF file
KMKazuo Momma
Kazuo Momma
KTKatsuaki Toyoshima
Katsuaki Toyoshima
FSFang Sun
Fang Sun
TNToshio Nakanishi
Toshio Nakanishi
Background: Fasudil hydrochloride, a Rho kinase inhibitor, was reported to dilate the constricted ductus arteriosus in vitro, and was suggested as a neonatal bridge to heart surgery. Objectives: To clarify the in vivo effectiveness of fasudil to dilate the neonatal ductus arteriosus, and its usefulness as a bridge to heart surgery. Methods: We studied the dose and timing of administration of fasudil in the neonatal rat. Postnatal ductal closure was studied on the 21st gestational day following cesarean section and incubation for 30–480 min in room air at 33°C, with a rapid whole-body freezing method. In control rats, the ductus closed rapidly after birth, and the ductal diameter was 0.80 and 0.12 mm at 0 and 30 min after birth. Fasudil was injected peritoneally into the neonate, and the ductus was studied 30 min after injection and 60 min after birth. Results: Fasudil, 10 mg/kg, injected within 5 min after birth, dilated the ductus completely to 0.8 mm, and the dose used clinically, 1 mg/kg, dilated the ductus to 0.4 mm. The ductus-dilating effect of fasudil decreased rapidly as the neonatal ductus constricted. Fasudil, 100 mg/kg, dilated the ductus completely, but induced severe respiratory depression and frequent death in 1-hour-old rats. Conclusions: Fasudil dilates the neonatal ductus arteriosus dose-dependently in the rat. Fasudil in large doses dilates the neonatal ductus completely, but is associated with fatal side effects, including respiratory depression.

1 January 1998 in Japanese Circulation Journal
Verified
Journal Article
Closed access
PDF file
SOShinichi Oho
Shinichi Oho
AIAkira Ishizawa
Akira Ishizawa
KKKazuyuki Koike
Kazuyuki Koike
TKToshiki Kobayashi
Toshiki Kobayashi
TNToshio Nakanishi
Toshio Nakanishi
HKHirohisa Kato
Hirohisa Kato
A multicenter clinical trial of DuctOcclud, a new detachable coil for transcatheter occlusion of patent ductus arteriosus (PDA), was conducted. DuctOcclud was used in 35 patients (12 male and 23 female) for transcatheter occlusion of PDA between January, 1996, and April, 1997. The age of the patients ranged from 0.5 to 27.2 years (median 7.6 years) and weight from 6.3 to 70.0 kg (median 23.0 kg). The smallest diameter of PDA was 2.0±0.7 mm (range 1.0-3.3 mm). Pulmonary-systemic flow ratio (Qp/Qs) was 1.3±0.3 (range 1.0-2.2). The coils were successfully implanted in 32 (91%) patients. Of 31 patients who were followed 6 months after the procedure, 26 (84%) had no residual shunt and 5 (16%) had trivial residual shunt. One patient had infective endocarditis 1 month after the procedure but recovered completely. There were no incidences of coil embolization, hemolysis, late coil migration, or pulmonary artery stenosis. We conclude that DuctOcclud is a safe and effective device of transcatheter occlusion of PDA. (Jpn Circ J 1998; 62: 489 - 493)